Study Builds at Pandemic Speed: The Evolving Global Landscape of Clinical Trials
The need to rapidly develop both a preventive and therapeutic intervention against COVID-19 has propelled the pharmaceutical industry into action. The demand for the reduction in study build times requires agile adoption of technology, process, and resources. Speed,...
Clinical Trial Flexibility and Customization Needs that are Required by Biotechs and Next Generation Therapies
COVID-19 has ushered in new challenges when conducting clinical trials, but mid-tier biotech companies have different needs than large pharmaceutical companies. When companies are conducting studies for therapeutic areas such as oncology, or clinical trials for...
Managing Global Studies with Regional Partners
Wanting to learn about the benefits of managing global studies with regional partners? Tune in to the Endpoints News webinar below sponsored by Catalyst and Novotech and featuring CE3 Inc.’s Julie Bowman and Leap Therapeutics. In this webinar, you’ll learn...
Panel Discussion on Decentralized Trials: A Real-World Example
Catalyst Clinical Research had the opportunity to exhibit at Arena International Event Group’s Outsourcing in Clinical Trials USA Virtual Experience 2020. Additionally, our experts participated in a panel discussion on decentralized trials, discussing their use...
